JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EFF
2876
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
| $3.09M | ﹤0.01% |
208,629
-54,285
| -21% | -$809K |
2014 Q3
18 quarters
|
|
2877
JPMorgan Diversified Return International Equity ETF
JPIN
$374M
| $3.06M | ﹤0.01% |
55,355
-563,222
| -91% | -$30.7M |
2015 Q1
16 quarters
|
|
2878
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.8B
| $3.06M | ﹤0.01% |
93,963
+17,797
| +23% | +$574K |
2017 Q2
7 quarters
|
|
2879
Ligand Pharmaceuticals
LGND
$5.92B
| $3.06M | ﹤0.01% |
38,975
-72,568
| -65% | -$5.5M |
2015 Q4
13 quarters
|
|
2880
Cannae Holdings
CNNE
$672M
| $3.06M | ﹤0.01% |
125,952
-18,527
| -13% | -$390K |
2017 Q4
5 quarters
|
|
|
CIM
2881
Chimera Investment
CIM
$770M
| $3.05M | ﹤0.01% |
54,320
-91,989
| -63% | -$5.17M |
2013 Q2
23 quarters
|
|
2882
PUT
PNC Financial Services
PNC
$87.8B
| $3.05M | ﹤0.01% |
24,900
| – | – |
2018 Q4
1 quarter
|
|
|
HTLF
2883
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.05M | ﹤0.01% |
71,585
-2
| -0% | -$93 |
2013 Q2
23 quarters
|
|
2884
S&T Bancorp
STBA
$1.72B
| $3.05M | ﹤0.01% |
77,187
-18,945
| -20% | -$758K |
2013 Q2
23 quarters
|
|
|
CVGW
2885
DELISTED
Calavo Growers
CVGW
| $3.05M | ﹤0.01% |
36,353
-27,052
| -43% | -$2.2M |
2013 Q2
23 quarters
|
|
2886
Arlo Technologies
ARLO
$1.38B
| $3.05M | ﹤0.01% |
737,875
+734,846
| +24,260% | +$4.07M |
2018 Q3
2 quarters
|
|
2887
iShares US Medical Devices ETF
IHI
$3.49B
| $3.04M | ﹤0.01% |
78,804
-5,148
| -6% | -$187K |
2015 Q4
13 quarters
|
|
2888
Lakeland Financial Corp
LKFN
$1.44B
| $3.04M | ﹤0.01% |
67,218
-11,083
| -14% | -$505K |
2013 Q2
23 quarters
|
|
2889
Resideo Technologies
REZI
$2.87B
| $3.04M | ﹤0.01% |
157,388
-35,590
| -18% | -$789K |
2018 Q4
1 quarter
|
|
2890
CALL
Nektar Therapeutics
NKTR
$1.36B
| $3.02M | ﹤0.01% |
6,000
+2,333
| +64% | +$1.38M |
2018 Q2
3 quarters
|
|
2891
Strategic Education
STRA
$1.77B
| $3.02M | ﹤0.01% |
23,026
-23,194
| -50% | -$2.83M |
2013 Q2
23 quarters
|
|
2892
PUT
Archer Daniels Midland
ADM
$39.6B
| $3.02M | ﹤0.01% |
+70,000
| New | +$2.99M |
2019 Q1
0 quarters
|
|
2893
CALL
Suncor Energy
SU
$79.8B
| $3.02M | ﹤0.01% |
+93,100
| New | +$3.03M |
2019 Q1
0 quarters
|
|
|
2894
PUT
Suncor Energy
SU
$79.8B
| $3.02M | ﹤0.01% |
+93,100
| New | +$3.03M |
2019 Q1
0 quarters
|
|
2895
Gran Tierra Energy
GTE
$370M
| $3.02M | ﹤0.01% |
132,871
+4,620
| +4% | +$108K |
2017 Q2
7 quarters
|
|
|
MXIM
2896
PUT
DELISTED
Maxim Integrated Products
MXIM
| $3.02M | ﹤0.01% |
56,700
-9,900
| -15% | -$532K |
2018 Q3
2 quarters
|
|
2897
Ericsson
ERIC
$30.7B
| $3.01M | ﹤0.01% |
328,263
+326,855
| +23,214% | +$2.95M |
2013 Q2
23 quarters
|
|
|
AFI
2898
DELISTED
Armstrong Flooring, Inc.
AFI
| $3.01M | ﹤0.01% |
221,535
-53,840
| -20% | -$735K |
2016 Q4
9 quarters
|
|
|
RRD
2899
DELISTED
RR Donnelley & Sons Co.
RRD
| $3.01M | ﹤0.01% |
638,245
-127,300
| -17% | -$656K |
2016 Q4
9 quarters
|
|
2900
OneSpan
OSPN
$677M
| $3M | ﹤0.01% |
156,307
-31,052
| -17% | -$528K |
2015 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.